The BioCentury Show

About The BioCentury Show

Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine.Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues.The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how science is being turned into medicine.Don't miss this event, every two weeks, now available as a video webcast or audio podcast (https://www.biocentury.com/the-biocentury-show/watch-or-listen).

Publisher

BioCentury

Category

business · science · science

Language

en

Explicit

No

First episode

17 Apr 2024

Latest episode

18 Sept 2026

Latest episodes

74 episodes in the feed.

1. 

   18 Sept 2026

   Ep. 119 - Blackstone's Galakatos on funding biotech's hardest mile

   On this edition of The BioCentury Show, Nick Galakatos, Global Head of Life Sciences at Blackstone, joins Editor in Chief Simone Fishburn to discuss the path from Clarus to Blackstone's new $6.3 billion fund, and the goal of game-changing bets. Galakatos discusses Blackstone's thesis for addressing the late-stage financing gap, as Phase III programs costing more than $1 billion drive demand for large, product-based capital. He also addresses structured capital as an alternative to acquisition...

2. 

   4 Sept 2026

   Ep. 118 - Regeneron's Gonçalo Abecasis on turning genetic data into drug targets

   On This Edition of The BioCentury Show, Gonçalo Abecasis, SVP and Chief Genomics and Data Sciences Officer at the Regeneron Genetics Center, joins BioCentury’s Tierney Baum to discuss genetics as a scalable drug discovery platform and the practical use of AI in genomics. View full story: https://www.biocentury.com/article/660697 #Genomics #DrugDiscovery #AI #GeneticMedicines #ClinicalTrials 0:00 - Introduction 1:14 - Regeneron Genetics Center 10:29 - Acting on Genetic Signals 16:57 ...

3. 

   21 Aug 2026

   Ep. 117 - C-Path's Klaus Romero on moving genetic medicines beyond one patient

   The Critical Path Institute’s One to Millions Initiative is using individualized rare disease therapies as the starting point for a development framework that could eventually extend across all genetically defined diseases. The initiative seeks to bring form to FDA’s Plausible Mechanism Framework by standardizing how evidence and methods can be reused across therapies and patients. In conversation with Biopharma Analyst Dr. Tierney Baum on The BioCentury Show, C-Path CEO and CSO Klaus Romero ...

Who has been a guest on The BioCentury Show

Names identified in recent episode analyses. Showing up to five guests.

• Karen Knudsen
• Chris Hollowood
• Sander Slootweg
• Daniel Mahony
• Najat Khan

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

YouTube views

37,894

Score snapshot 15 Sept 2025

Apple Podcasts (US)

4.6 / 5

11 ratings

Spotify

5.0 / 5

10 ratings

Podcast Authority Score: 60 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

55

Social presence

0

YouTube

85

Engagement

77

Pitching The BioCentury Show

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting pitches.

Shows with a similar audience

• 

  BioCentury This Week

• 

  Biotech Hangout

• 

  The Long Run with Luke Timmerman

• 

  The Readout Loud

• 

  Biotech 2050 Podcast

• 

  Business Of Biotech

Questions about The BioCentury Show